Fundraising Fox
Astraea
YC X26San Francisco, US · Founded 2026 · Delaware corporation · 6 employees · Hiring · 9 known investors
Find your way into Astraea
Sign up to see every warm intro you have to Astraea
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Astraea team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.
Also known as Omni Financial Technologies, Inc.
Founders & leadership· Y Combinator alumni (X26)
Astraea was founded in 2026 by Joshua Wang and Sanmay Sarada.
Investors · 9
How we know: the company's own site · the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · eightcapital.com · Not right? Tell us
How we know: satellitetoday.com · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Also in the syndicate · 4
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 5 rounds · 2017–2022
▶$6.4MraisedJul 2022 · 15 investors · Other TechnologyRule 506(b)
- Daniel BaileyExecutive Officer, Director
- Thomas BartonDirector
- Walter R. Bashaw IIDirector
- Eric T. YonkeDirector
- Geoff WoolleyDirector
- Brendan RichardsonExecutive Officer, Director
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedSep 2020 · 9 investors · Other TechnologyRule 506(b)
- Jon WattsDirector
- Thomas BartonDirector
- Brendan RichardsonExecutive Officer, Director
- Eric T. YonkeDirector
- Geoff WoolleyDirector
- Daniel BaileyExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $3.7M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.6MraisedSep 2020 · 10 investors · Other TechnologyRule 506(b)
- Walter R. BashawDirector
- Brendan RichardsonExecutive Officer, Director
- Geoff WooleyDirector
- Eric T. YonkeDirector
- Jon WattsDirector
- Tom BartonDirector
- Daniel BaileyDirector
- Offering amount
- $4.7M
- Amount sold
- $3.6M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$465KraisedJul 2018 · 7 investors · Other TechnologyRule 506(b)
- Geoff WooleyDirector
- Brendan RichardsonExecutive Officer, Director
- Walter R. BashawDirector
- Eric T. YonkeDirector
- Daniel BaileyDirector
- Offering amount
- $600K
- Amount sold
- $465K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.2MraisedSep 2017 · 6 investors · Other TechnologyRule 506(b)
- Brendan RichardsonExecutive Officer, Director
- Daniel BaileyDirector
- Offering amount
- $3.6M
- Amount sold
- $3.2M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Legal entities · 1
corporate structureIn the news
Frequently asked questions
- What does Astraea do?
- Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.
- Who founded Astraea?
- Astraea was founded by Joshua Wang, Sanmay Sarada in 2026.
- Who are Astraea's investors?
- Astraea's investors include Y Combinator, Eight Capital, Aligned Climate Capital, Founders Factory, Friale.
- How much funding has Astraea raised?
- Astraea has disclosed $17.3M raised across 5 rounds.
- Where is Astraea headquartered?
- Astraea is headquartered in San Francisco, US.